COLUMBIA, SC–(Marketwire – March 10, 2010) –  BDI Pharma, Inc. (BDI), the fastest growing national distributor of biotech therapies, recognized two distinct milestones during the first quarter of 2010 — 15 years in business and the first anniversary of the organization’s re-branding. BDI was founded on January 27, 1995 as Blood Diagnostics, Inc. focusing primarily upon products that comprise the plasma derivative and recombinant pharmaceutical market. In the latter half of 2007, the process of significantly expanding the company’s portfolio began. The success of this expansion ultimately resulted in the organization’s …

American Cancer Society’s New Screening Guidelines

MOUNTAINSIDE, NJ–(Marketwire – March 10, 2010) –  Proteonomix, Inc. (PINKSHEETS: PROT) announces that its wholly-owned subsidiary, Proteonomix Regenerative Translational Medicine Institute, Inc. (”PRTMI”), has created a subsidiary, PRTMI RD S.R.L., a corporation organized under the laws of the Dominican Republic (”DR”).

Hildreth Accompanies Richmond Bone & Joint Colleagues to Aid Effort and Medical Teams Still Overwhelmed Weeks Following the Devastating Earthquake

SUN VALLEY, CA–(Marketwire – March 10, 2010) –  XTend Medical (PINKSHEETS: XMDC), a company that specializes in delivering life-changing medical technology to healthcare organizations globally, announced today that the company has filed legal action against U & I Bio-Tech, Korea and California, as well as Mr. Sam Lee personally, for their failure to deliver all BioHarp-related assets acquired pursuant to the Asset Purchase Agreement signed on December 8, 2009. The case, captioned as XTend Medical Corp. v. Lee, was filed on Monday, March 8, 2010 and is pending in the United States …